Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

BMO Capital Markets and Canaccord Genuity Group top M&A financial advisers in metals & mining sector during Q1-Q3 2023, finds GlobalData

BMO Capital Markets and Canaccord Genuity Group were the top mergers and acquisitions (M&A) financial advisers in the metals & mining sector during the first three quarters (Q1-Q3) of 2023 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, which ranks financial advisers by the value and volume of […]
Read more

Weil, Gotshal & Manges and Fasken Martineau DuMoulin top M&A legal advisers in metals & mining sector during Q1-Q3 2023, finds GlobalData

Weil, Gotshal & Manges and Fasken Martineau DuMoulin were the top mergers and acquisitions (M&A) legal advisers in the metals & mining sector during the first three quarters (Q1-Q3) of 2023 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, which ranks legal advisers by the value and volume […]
Read more

ScS sitting comfortably after acquisition, says GlobalData

Following the news that ScS has agreed to a £99.4m sale to the Italian upholstery vertical Poltronesofà; Matt Walton, Senior Data Analyst for Retail, at GlobalData, a leading data and analytics company, offers his view: “ScS is set to become a greater threat within the UK furniture market after it agreed to be sold to […]
Read more

WHO’s move for regulation of AI in healthcare highlights risks posed by usage of AI tools, says GlobalData

The World Health Organization (WHO) has outlined several considerations for the regulation of artificial intelligence (AI) in healthcare. The WHO recently released a new publication, in which it listed key regulatory considerations, which touch on the importance of establishing safety and effectiveness in AI tools, making systems available to those who need them, and fostering […]
Read more

Golidocitinib’s anti-tumor efficacy in PTCL will pave way for new treatment approach in China, says GlobalData

Dizal (Jiangsu) Pharmaceutical Co Ltd’s golidocitinib was granted priority review designation by the China National Medical Products Administration (NMPA) in September 2023. As a result, golidocitinib is expected to evolve as a potential therapeutic option for peripheral T-cell lymphoma (PTCL), a type of non-Hodgkin lymphoma (NHL) in China upon receiving regulatory approval, says GlobalData, a […]
Read more

Gaucher Disease Awareness Month highlights serious unmet need from lack of neuronopathic therapies, says GlobalData

In the midst of International Gaucher Disease Awareness Month, which is observed in October every year, GlobalData sheds light on a critical issue within the Gaucher disease landscape: the significant lack of neuronopathic therapies. Gaucher disease, a rare inherited metabolic disorder caused by mutations in the GBA1 gene, poses challenges for patients and physicians, especially […]
Read more

Bicycle Health, Override Health partnership to significantly impact healthcare IT industry, says GlobalData

The current era is witnessing remarkable advancements in telehealth, healthcare technology, and innovations in patient care. Early in October, Bicycle Health and Override Health partnered in the fight against opioid use disorder (OUD) and chronic pain. This dynamic partnership could have a large impact on the healthcare IT industry as well as transform patient care, […]
Read more

China to dominate acrylonitrile butadiene styrene capacity additions in Asia by 2027, forecasts GlobalData

China is forecast to register the highest acrylonitrile butadiene styrene (ABS) capacity additions in Asia, contributing about 96% of the region’s capacity additions by 2027, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Acrylonitrile-Butadiene-Styrene (ABS) Industry Capacity and Capital Expenditure Forecasts with Details of Active and Planned Plants to 2027”, reveals that […]
Read more

Asia to lead global acrylonitrile butadiene styrene capacity additions by 2027, says GlobalData

Asia is set to lead the global acrylonitrile butadiene styrene (ABS) industry capacity additions with a share of 98% by 2027, by gaining capacities from new-build and expansion projects between 2023 and 2027, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Acrylonitrile-Butadiene-Styrene (ABS) Industry Capacity and Capital Expenditure Forecasts with Details […]
Read more

Physicians using AI in clinical practice see lack of in-person interaction as major concern, finds Globaldata

Artificial intelligence (AI) algorithms can analyze vast amounts of patient data, identify patterns and trends, and make predictions based on this information. This technology can help doctors make more accurate diagnosis, recommend the most effective treatment, and even predict patient outcomes. While AI holds the potential to enhance patient care, it is accompanied by a […]
Read more

Sullivan & Cromwell and Machado Meyer Sendacz e Opice top M&A legal advisers by value and volume in South & Central America during Q1-Q3 2023, finds GlobalData

Sullivan & Cromwell and Machado Meyer Sendacz e Opice were the top mergers and acquisitions (M&A) legal advisers in the South & Central American region by value and volume, respectively, during the first three quarters (Q1-Q3) of 2023, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An […]
Read more

Bank of America and Rothschild & Co top M&A financial advisers by value, volume in Middle East & Africa in Q1-Q3 2023, finds GlobalData

Bank of America and Rothschild & Co were the top mergers and acquisitions (M&A) financial advisers in the Middle East & African region during the first three quarters (Q1-Q3) of 2023 by value and volume, respectively, according to the latest Financial Advisers League Table by GlobalData, which ranks financial advisers by the value and volume […]
Read more

Ionis’ Olezarsen holds potential to overcome dyslipidemia unmet needs, says GlobalData

In September 2023, Ionis Pharmaceuticals unveiled positive Phase III clinical data for olezarsen, a ligand-conjugated antisense (LICA) designed to inhibit apolipoprotein C-III (apoC-III). Phase III studies showed a significant reduction in triglycerides in patients with familial chylomicronemia syndrome (FCS) taking 80mg of olezarsen monthly for six months. The drug holds the potential to overcome dyslipidemia […]
Read more

Herbert Smith Freehills and AZB & Partners top M&A legal advisers by value, volume in APAC during Q1-Q3 2023, finds GlobalData

Herbert Smith Freehills and AZB & Partners were the top mergers and acquisitions (M&A) legal advisers in the Asia-Pacific (APAC) region during the first three quarters (Q1-Q3) of 2023 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, which ranks legal advisers by the value and volume of M&A […]
Read more
1 … 97 98 99 100 101 … 136